[Evidence 2: therapeutic management of migraine headache in adults and children and economic aspects].
D000328:Adult; D000700:Analgesics / Q000191:economics / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000191:economics / Q000627:therapeutic use; D001521:Behavior Therapy; D002648:Child; D000529:Complementary Therapies; D017281:Cost of Illness; D006801:Humans; D008881:Migraine Disorders / Q000188:drug therapy / Q000191:economics* / Q000628:therapy*; D017366:Serotonin Receptor Agonists / Q000191:economics / Q000627:therapeutic use; D013256:Steroids
D000700:Analgesics; D000893:Anti-Inflammatory Agents; D017366:Serotonin Receptor Agonists; D013256:Steroids